Corcept Therapeutics Incorporated (CORT)

NASDAQ: CORT · Real-Time Price · USD

90.47

+4.57 (5.32%)

At close: Jul 14, 2026, 4:00 PM EDT

91.52

+1.05 (1.16%)

Pre-market: Jul 15, 2026, 6:45 AM EDT

Corcept Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	9,712	3,688	5,297	3,359	2,190	2,098
Market Cap Growth	23.21%	-30.38%	57.70%	53.35%	4.41%	-31.31%
Enterprise Value	9,206	3,322	4,920	2,991	1,760	1,875
Last Close Price	90.47	34.80	50.39	32.48	20.31	19.80
PE Ratio	225.05	42.44	40.97	34.55	23.34	22.25
Forward PE	64.74	55.53	32.11	32.61	19.95	21.01
PEG Ratio	-	1.96	1.96	1.96	1.96	1.50
PS Ratio	12.63	4.84	7.85	6.96	5.45	5.73
PB Ratio	15.22	5.69	7.79	6.63	4.36	5.58
P/TBV Ratio	16.46	6.45	8.41	7.16	4.69	6.64
P/FCF Ratio	80.84	26.01	27.01	26.54	18.26	12.53
P/OCF Ratio	80.63	25.97	26.71	26.51	18.20	12.49
EV/Sales Ratio	11.97	4.36	7.29	6.20	4.38	5.12
EV/EBITDA Ratio	-	72.29	35.72	27.61	15.45	14.88
EV/EBIT Ratio	-	74.15	35.93	27.88	15.62	15.06
EV/FCF Ratio	76.63	23.43	25.09	23.63	14.67	11.20
Debt / Equity Ratio	0.01	0.01	0.01	0	0	0
Debt / EBITDA Ratio	-	0.13	0.05	0.00	0.01	0.00
Debt / FCF Ratio	0.08	0.04	0.04	0.00	0.01	0.00
Net Debt / Equity Ratio	-0.51	-0.56	-0.55	-0.73	-0.86	-0.59
Net Debt / EBITDA Ratio	48.62	-7.97	-2.73	-3.40	-3.78	-1.77
Net Debt / FCF Ratio	-2.74	-2.58	-1.92	-2.91	-3.59	-1.33
Asset Turnover	0.93	0.91	0.92	0.80	0.80	0.74
Inventory Turnover	1.04	1.03	1.08	0.94	0.97	1.07
Quick Ratio	2.53	2.60	3.11	4.05	6.58	5.28
Current Ratio	2.86	2.92	3.35	4.39	6.89	5.60
Return on Equity (ROE)	7.36%	15.01%	23.81%	21.05%	23.11%	25.03%
Return on Assets (ROA)	-3.89%	8.01%	16.38%	15.17%	19.52%	22.51%
Return on Invested Capital (ROIC)	-10.85%	22.96%	54.21%	87.09%	87.74%	94.15%
Return on Capital Employed (ROCE)	-1.23%	6.54%	22.51%	20.87%	25.39%	27.65%
Earnings Yield	0.48%	2.36%	2.44%	2.89%	4.28%	4.49%
FCF Yield	1.24%	3.84%	3.70%	3.77%	5.48%	7.98%
Buyback Yield / Dilution	-0.16%	-5.73%	-1.56%	3.64%	7.94%	-1.42%
Total Shareholder Return	-0.16%	-5.73%	-1.56%	3.64%	7.94%	-1.42%

SEC Filings: 10-K · 10-Q